Mass Flows of X-ray Contrast Media and Cytostatics in Hospital Wastewater

Weissbrodt, David, Kovalova, Lubomira, Ort, Christopher, Pazhepurackel, Vinitha, Moser, Ruedi, Hollender, Juliane, Siegrist, Hansruedi and Mcardell, Christa S. (2009) Mass Flows of X-ray Contrast Media and Cytostatics in Hospital Wastewater. Environmental Science & Technology, 43 13: 4810-4817. doi:10.1021/es8036725

Author Weissbrodt, David
Kovalova, Lubomira
Ort, Christopher
Pazhepurackel, Vinitha
Moser, Ruedi
Hollender, Juliane
Siegrist, Hansruedi
Mcardell, Christa S.
Title Mass Flows of X-ray Contrast Media and Cytostatics in Hospital Wastewater
Journal name Environmental Science & Technology   Check publisher's open access policy
ISSN 0013-936X
Publication date 2009-05-01
Year available 2009
Sub-type Article (original research)
DOI 10.1021/es8036725
Volume 43
Issue 13
Start page 4810
End page 4817
Total pages 8
Editor Jerald Schnoor
Place of publication United States
Publisher American Chemical Society
Collection year 2010
Language eng
Subject C1
Abstract Little is known about the significance of hospitals as point sources for emission of organic micropollutants into the aquatic environment. A mass flow analysis of pharmaceuticals and diagnostics used in hospitals was performed on the site of a representative Swiss cantonal hospital. Specifically, we analyzed the consumption of iodinated X-ray contrast media (ICM) and cytostatics in their corresponding medical applications of radiology and oncology, respectively, and their discharge into hospital wastewater and eventually into the wastewater of the municipal wastewater treatment plant. Emission levels within one day and over several days were found to correlate with the pharmacokinetic excretion pattern and the consumed amounts in the hospital during these days. ICM total emissions vary substantially from day to day from 255 to 1259 g/d, with a maximum on the day when the highest radiology treatment occurred. Parent cytostatic compounds reach maximal emissions of 8−10 mg/d. A total of 1.1%, 1.4%, and 3.7% of the excreted amounts of the cytostatics 5-fluorouracil, gemcitabine, and 2′,2′-difluorodeoxyuridine (main metabolite of gemcitabine), respectively, were found in the hospital wastewater, whereas 49% of the total ICM was detected, showing a high variability among the compounds. These recoveries can essentially be explained by the high amount administered to out-patients (70% for cytostatics and 50% for ICM); therefore, only part of this dose is expected to be excreted on-site. In addition, this study emphasizes critical issues to consider when sampling in hospital sewer systems. Flow proportional sampling over a longer period is crucial to compute robust hospital mass flows.
Keyword mass flows
hospital wastewater
References 1. Kummerer, K.Drugs in the environment. Emission of drugs, diagnostic aids, and disinfectants into wastewater by hospitals in relation to other sources: A review Chemosphere 2001, 45, 957– 969[CrossRef], [PubMed], [ChemPort] 2. Fent, K.; Weston, A. A.; Caminada, D.Ecotoxicology of human pharmaceuticals Aquat. Toxicol. 2006, 76, 122– 159[CrossRef], [PubMed], [ChemPort] 3. Moser, R.; McArdell, C. S.; Weissbrodt, D.Micropollutants from urban drainage: Pretreatment of hospital wastewater GWA Gas, Wasser, Abwasser 2007, 11, 869– 875 4. Prez, S.; Barcel, D.Fate and occurrence of X-ray contrast media in the environment Anal. Bioanal. Chem. 2007, 387, 1235– 1246[CrossRef], [PubMed], [ChemPort] 5. Heinzmann, B.; Schwarz, R.-J.; Schuster, P.; Pineau, C.Decentralized collection of iodinated X-ray contrast media in hospitals: Results of the feasibility study and the practice test phase Water Sci. Technol. 2008, 57, 209– 215[CrossRef], [PubMed], [ChemPort] 6. Kummerer, K.; Al-Ahmad, A.Biodegradability of the anti-tumour agents 5-fluorouracil, cytarabine, and gemcitabine: Impact of the chemical structure and synergistic toxicity with hospital effluent Acta Hydrochim. Hydrobiol. 1997, 25, 166– 172[CrossRef], [ChemPort] 7. Mahnik, S. N.; Lenz, K.; Weissenbacher, N.; Mader, R. M.; Fuerhacker, M.Fate of 5-fluorouracil, doxorubicin, epirubicin, and daunorubicin in hospital wastewater and their elimination by activated sludge and treatment in a membrane−bioreactor system Chemosphere 2007, 66, 30– 37[CrossRef], [PubMed], [ChemPort] 8. Mahnik, S. N.; Rizovski, B.; Fuerhacker, M.; Mader, R. M.Determination of 5-fluorouracil in hospital effluents Anal. Bioanal. Chem. 2004, 380, 31– 35[CrossRef], [PubMed], [ChemPort] 9. Heberer, T.; Feldmann, D.Contribution of effluents from hospitals and private households to the total loads of diclofenac and carbamazepine in municipal sewage effluents: Modeling versus measurements J. Hazard. Mater. 2005, 122, 211– 218[CrossRef], [PubMed], [ChemPort] 10. Feldmann, D. F.; Zuehlke, S.; Heberer, T.Occurrence, fate, and assessment of polar metamizole (dipyrone) residues in hospital and municipal wastewater Chemosphere 2008, 71, 1754– 1764[CrossRef], [PubMed], [ChemPort] 11. Hartmann, A.; Alder, A. C.; Koller, T.; Widmer, R. M.Identification of fluoroquinolone antibiotics as the main source of umuC genotoxicity in native hospital wastewater Environ. Toxicol. Chem. 1998, 17, 377– 382[CrossRef], [ChemPort] 12. Giger, W.; Alder, A. C.; Golet, E. M.; Kohler, H. P. E.; McArdell, C. S.; Molnar, E.; Siegrist, H.; Suter, M. J. F.Occurrence and fate of antibiotics as trace contaminants in wastewaters, sewage sludges, and surface waters Chimia 2003, 57, 485– 491[CrossRef], [ChemPort] 13. Rousseau, J.; Boudou, C.; Esteve, F.; Elleaume, H.Convection-enhanced delivery of an iodine tracer into rat brain for synchrotron stereotactic radiotherapy Int. J. Radiat. Oncol., Biol., Phys. 2007, 68, 943– 951[PubMed], [ChemPort] 14. Peters, G. J.; van der Wilt, C. L.; van Moorsel, C. J. A.; Kroep, J. R.; Bergman, A. M.; Ackland, S. P.Basis for effective combination cancer chemotherapy with antimetabolites Pharmacol. Ther. 2000, 87, 227– 253[CrossRef], [PubMed], [ChemPort] 15. Buerge, I. J.; Buser, H. R.; Poiger, T.; Mller, M. D.Occurrence and fate of the cytostatic drugs cyclophosphamide and ifosfamide in wastewater and surface waters Environ. Sci. Technol. 2006, 40, 7242– 7250[ACS Full Text ], [PubMed], [ChemPort] 16. Ferk, F.; Misik, M.; Grummt, T.; Majer, B.; Fuerhacker, M.; Buchmann, C.; Vital, M.; Uhl, M.; Lenz, K.; Grillitsch, B.; Parzefall, W.; Nersesyan, A.; Knasmuller, S.Genotoxic effects of wastewater from an oncological ward Mutat. Res. Genet. Toxicol. Environ. Mutagen. 2009, 672, 69– 75[CrossRef], [PubMed], [ChemPort] 17. Zounkova, R.; Odraska, P.; Dolezalova, L.; Hilscherova, K.; Marsalek, B.; Blaha, L.Ecotoxicity and genotoxicity assessment of cytostatic pharmaceuticals Environ. Toxicol. Chem. 2007, 26, 2208– 2214[CrossRef], [PubMed], [ChemPort] 18. Ternes, T. A.; Hirsch, R.Occurrence and behavior of X-ray contrast media in sewage facilities and the aquatic environment Environ. Sci. Technol. 2000, 34, 2741– 2748[ACS Full Text ], [ChemPort] 19. Pauwels, B.; Verstraete, W.The treatment of hospital wastewater: An appraisal J. Water Health 2006, 4, 405– 416[PubMed], [ChemPort] 20. Boillot, C.; Bazin, C.; Tissot-Guerraz, F.; Droguet, J.; Perraud, M.; Cetre, J. C.; Trepo, D.; Perrodin, Y.Daily physicochemical, microbiological, and ecotoxicological fluctuations of a hospital effluent according to technical and care activities Sci. Total Environ. 2008, 403, 113– 129[CrossRef], [PubMed], [ChemPort] 21. Kennzahlen der Schweizer Spitler 2004; Bundesamt fr Gesundheit BAG: 2006. 22. Oppliger, A.; Hilfiker, S.; Vu Duc, T.Influence of seasons and sampling strategy on assessment of bioaerosols in sewage treatment plants in Switzerland Ann. Occup. Hyg. 2005, 49, 393– 400[CrossRef], [PubMed], [ChemPort] 23. Ort, C.; Gujer, W.Sampling for representative micropollutant loads in sewer systems Water Sci. Technol. 2006, 54, 169– 176[PubMed], [ChemPort] 24. Ternes, T. A.; Bonerz, M.; Herrmann, N.; Loffler, D.; Keller, E.; Lacida, B. B.; Alder, A. C.Determination of pharmaceuticals, iodinated contrast media, and musk fragrances in sludge by LC/tandem MS and GC/MS J. Chromatogr., A 2005, 1067, 213– 223[CrossRef], [PubMed], [ChemPort] 25. Kovalova, L.; McArdell, C. S.; Hollender, J.Challenge of high polarity and low concentrations in analysis of cytostatics and metabolites in wastewater by hydrophilic interaction chromatography/tandem mass spectrometry. J. Chromatogr., A 2009, 1216, 1100−1108. 26. Heggie, G. D.; Sommadossi, J.; Cross, D. S.; Huster, W. J.; Diasio, R. B.Clinical pharmacokinetics of 5-fluorouracil and its metabolites in plasma, urine, and bile Cancer Res. 1987, 47, 2203– 2206[PubMed], [ChemPort] 27. Swiss Compendium of Medicines; Documed SA: Basel, Switzerland, 2007. 28. Diasio, R. B.; Harris, B. E.Clinical pharmacology of 5-fluorouracil Clin. Pharmacokinet. 1989, 16, 215– 237[CrossRef], [PubMed], [ChemPort] 29. Judson, I. R.; Beale, P. J.; Trigo, J. M.; Aherne, W.; Crompton, T.; Jones, D.; Bush, E.; Reigner, B.A human capecitabine excretion balance and pharmacokinetic study after administration of a single oral dose of 14C-labelled drug Invest. New Drugs 1999, 17, 49– 56[CrossRef], [PubMed], [ChemPort] 30. Abbruzzese, J. L.; Grunewald, R.; Weeks, E. A.; Gravel, D.; Adams, T.; Nowak, B.; Mineishi, S.; Tarassoff, P.; Satterlee, W.; Raber, M. N.A phase I clinical, plasma, and cellular pharmacology study of gemcitabine J Clin. Oncol. 1991, 9, 491– 498[PubMed], [ChemPort] 31. Kalsch, W.Biodegradation of the iodinated X-ray contrast media diatrizoate and iopromide Sci. Total Environ. 1999, 225, 143– 153[CrossRef], [PubMed], [ChemPort] 32. Joss, A.; Keller, E.; Alder, A. C.; Gobel, A.; McArdell, C. S.; Ternes, T.; Siegrist, H.Removal of pharmaceuticals and fragrances in biological wastewater treatment Water Res. 2005, 39, 3139– 3152[CrossRef], [PubMed], [ChemPort] 33. Schulz, M.; Lffler, D.; Wagner, M.; Ternes, T. A.Transformation of the X-ray contrast medium iopromide in soil and biological wastewater treatment Environ. Sci. Technol. 2008, 42, 7207– 7217[ACS Full Text ], [PubMed], [ChemPort] 34. Abegglen, C.; Joss, A.; McArdell, C. S.; Fink, G.; Schlüsener, M. P.; Ternes, T. A.; Siegrist, H.The fate of selected micropollutants in a single-house MBR. Water Res. 2009, 43, 2036–2046. 35. Kovalova, L.Cytostatics in the Aquatic Environment. Ph.D. Thesis , RWTH Aachen University: Aachen, Germany, 2009.
Q-Index Code C1
Q-Index Status Confirmed Code

Document type: Journal Article
Sub-type: Article (original research)
Collections: 2010 Higher Education Research Data Collection
Advanced Water Management Centre Publications
Version Filter Type
Citation counts: TR Web of Science Citation Count  Cited 55 times in Thomson Reuters Web of Science Article | Citations
Scopus Citation Count Cited 60 times in Scopus Article | Citations
Google Scholar Search Google Scholar
Created: Wed, 21 Apr 2010, 00:27:25 EST by Hong Lee on behalf of Advanced Water Management Centre